Literature DB >> 15521080

Early prediction of organ failure by combined markers in patients with acute pancreatitis.

P Mentula1, M-L Kylänpää, E Kemppainen, S-E Jansson, S Sarna, P Puolakkainen, R Haapiainen, H Repo.   

Abstract

BACKGROUND: Several biological markers and clinical scoring systems have been used to predict the course of acute pancreatitis. Because organ failure is the most severe complication of the disease, prognostic markers and their combinations that would predict organ failure on hospital admission were sought.
METHODS: Some 351 consecutive patients with acute pancreatitis were studied. Blood samples were taken within 12 h of admission. This case-control study included all 33 patients with organ failure and 99 matched controls without organ failure. Measurements included 19 prognostic markers and Acute Physiology And Chronic Health Evaluation (APACHE) II score.
RESULTS: Plasma interleukin 10, serum glucose and serum calcium were identified as independent predictors of organ failure by logistic regression analysis. Calcium level correlated with clinical onset of organ failure. The combination of interleukin 10 (more than 50 pg/ml) or calcium (less than 1.65 mmol/l) was a significantly better predictor than any single marker or APACHE II score, with a sensitivity of 88 per cent, specificity 93 per cent and diagnostic odds ratio 94.
CONCLUSION: Organ failure in acute pancreatitis can be predicted with high accuracy at hospital admission using a combination of plasma interleukin 10 and serum calcium measurements.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15521080     DOI: 10.1002/bjs.4786

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  31 in total

1.  Prediction of severe acute pancreatitis using classification and regression tree analysis.

Authors:  Wandong Hong; Lemei Dong; Qingke Huang; Wenzhi Wu; Jiansheng Wu; Yumin Wang
Journal:  Dig Dis Sci       Date:  2011-08-11       Impact factor: 3.199

2.  Emodin enhances alveolar epithelial barrier function in rats with experimental acute pancreatitis.

Authors:  Xian-Ming Xia; Fang-Yu Wang; Zhen-Kai Wang; Hai-Jun Wan; Wen-An Xu; Heng Lu
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

3.  Circulating cytokine levels in acute pancreatitis-model of SIRS/CARS can help in the clinical assessment of disease severity.

Authors:  Ivan Gunjaca; Josip Zunic; Mihaela Gunjaca; Zdenko Kovac
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 4.  Impaired glucose tolerance in acute pancreatitis.

Authors:  Kazuhiro Kikuta; Atsushi Masamune; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

5.  Alteration of peripheral blood lymphocyte subsets in acute pancreatitis.

Authors:  Miroslawa Pietruczuk; Milena I Dabrowska; Urszula Wereszczynska-Siemiatkowska; Andrzej Dabrowski
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

Review 6.  Immune-modulating therapy in acute pancreatitis: fact or fiction.

Authors:  Karolina Akinosoglou; Charalambos Gogos
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

7.  Cost-effectiveness analysis of early veno-venous hemofiltration for severe acute pancreatitis in China.

Authors:  Kun Jiang; Xin-Zu Chen; Qing Xia; Wen-Fu Tang; Lei Wang
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

Review 8.  Predictors of adverse outcomes in acute pancreatitis: new horizons.

Authors:  Rupjyoti Talukdar; D Nageshwar Reddy
Journal:  Indian J Gastroenterol       Date:  2013-03-12

Review 9.  Scoring of human acute pancreatitis: state of the art.

Authors:  Guido Alsfasser; Bettina M Rau; Ernst Klar
Journal:  Langenbecks Arch Surg       Date:  2013-05-17       Impact factor: 3.445

10.  Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury.

Authors:  R Mota; F Sánchez-Bueno; J J Berenguer-Pina; D Hernández-Espinosa; P Parrilla; J Yélamos
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.